A resurgent bioscience sector pulls Europe into recovery, while U.S. biotech leaders train the next generation of an essential skilled workforce. ...Read more ›
Stories about site selection and economic development in Belgium are included within this section.
As the global financial system continues to mend, venture capital is beginning to flow back into the biotechnology sector. In Europe, the largest biomed players are thriving, while entrepreneurial biotech start-ups gain traction in the U.S. From the March/April 2013 issue. ...Read more ›
Spillover effects are traveling back and forth between emerging and advanced economies. From the May/June 2012 issue. ...Read more ›